However, a clinical study found similar levels of Th1‐cytokine+ CD8+ T cells in patients with idiopathic CD4 lymphopenia compared to healthy controls after two or three doses of the SARS‐CoV‐2 mRNA vaccines [42], mirroring our results with the mouse model. This evidence concerns the gene CD8A and lymphopenia.